Turning Point Brands Inc (NYSE:TPB) Surges on Strong Q3 2025 Earnings and Revenue Beat

Turning Point Brands Inc (NYSE:TPB reported financial results for the third quarter of 2025 that surpassed analyst expectations, driven by explosive growth in its Modern Oral product category. The company's performance has been met with strong investor approval, reflected in significant pre-market share price appreciation.

Earnings and Revenue Performance Versus Estimates

The company delivered a substantial beat on both the top and bottom lines for the quarter ended September 30, 2025.

• Revenue: Reported net sales of $119.0 million, exceeding the analyst consensus estimate of approximately $111.3 million.
• Earnings Per Share (Non-GAAP): Posted Adjusted Diluted EPS of $1.27, which is significantly higher than the estimated $0.82. The GAAP diluted EPS was reported at $1.13.

This double beat demonstrates robust operational performance, with sales growing 31.2% and net income surging 70.3% compared to the same quarter last year.

Market Reaction

The market responded positively to the strong earnings report. Shares of Turning Point Brands experienced a notable uptick in pre-market trading, rising over 11%. This immediate price action indicates that investors were pleasantly surprised by the magnitude of the earnings and revenue beat, as well as the company's raised outlook for the remainder of the year.

Key Highlights from the Quarter

The quarter's success was largely fueled by the exceptional performance of the Stoker's segment and strategic capital management.

• Stoker's Segment Dominance: The Stoker's segment, which now constitutes 63% of total net sales, saw revenue skyrocket 80.8% year-over-year to $74.8 million. This growth was primarily driven by Modern Oral sales, which reached $36.7 million—a 628% increase over the prior year.
• Zig-Zag Segment Adjustment: Net sales in the Zig-Zag segment decreased by 10.5% to $44.2 million, which the company attributed to the planned wind-down of its Clipper business. Excluding this, the segment saw mid-single-digit sequential growth.
• Strengthened Balance Sheet: The company raised $97.5 million in net proceeds through an "At the Market" equity offering, significantly boosting its cash position to $201.2 million and total liquidity to $267.8 million. This capital is earmarked to accelerate the growth of the Modern Oral division.

Updated 2025 Outlook

Bolstered by its strong quarterly results, Turning Point Brands raised its full-year 2025 guidance.

• The company now projects Adjusted EBITDA to be in the range of $115.0 to $120.0 million, up from the previous guidance of $110.0 to $114.0 million.
• Modern Oral sales are now expected to reach $125.0 to $130.0 million for the full year, a considerable increase from the prior forecast of $100.0 to $110.0 million.

This raised outlook signals management's confidence in the sustained momentum of its high-growth product categories and exceeds the sales trajectory implied by analyst estimates for the year.

For a detailed breakdown of future earnings estimates and historical performance, you can review the earnings and estimates page for TPB.

---

Disclaimer: This article is for informational purposes only and does not constitute investment advice, financial analysis, or a recommendation to buy or sell any security. The information presented is based on publicly available data and should not be relied upon as the sole basis for an investment decision.